22 results on '"Dia Xenaki"'
Search Results
2. Dietary ω-6 polyunsaturated fatty acid arachidonic acid increases inflammation, but inhibits ECM protein expression in COPD
- Author
-
Sandra Rutting, Michael Papanicolaou, Dia Xenaki, Lisa G. Wood, Alexander M. Mullin, Philip M. Hansbro, and Brian G. Oliver
- Subjects
COPD ,ω-6 PUFAs ,Airway inflammation ,Remodelling ,Human pulmonary fibroblasts ,Diseases of the respiratory system ,RC705-779 - Abstract
Abstract Background The obesity paradox in COPD describes protective effects of obesity on lung pathology and inflammation. However, the underlying relationships between obesity, diet and disease outcomes in COPD are not fully understood. In this study we measured the response to dietary fatty acids upon markers of inflammation and remodelling in human lung cells from people with and without COPD. Methods Pulmonary fibroblasts were challenged with ω-3 polyunsaturated fatty acids (PUFAs), ω-6 PUFAs, saturated fatty acids (SFAs) or the obesity-associated cytokine TNFα. After 48–72 h release of the pro-inflammatory cytokines interleukin (IL)-6 and CXCL8 was measured using ELISA and mRNA expression and deposition of the extracellular matrix (ECM) proteins fibronectin, type I collagen, tenascin and perlecan were measured using qPCR or ECM ELISA, respectively. Results Challenge with the ω-6 PUFA arachidonic acid (AA), but not ω-3 PUFAs or SFAs, resulted in increased IL-6 and CXCL8 release from fibroblasts, however IL-6 and CXCL8 release was reduced in COPD (n = 19) compared to non-COPD (n = 36). AA-induced cytokine release was partially mediated by downstream mediators of cyclooxygenase (COX)-2 in both COPD and non-COPD. In comparison, TNFα-induced IL-6 and CXCL8 release was similar in COPD and non-COPD, indicating a specific interaction of AA in COPD. In patients with or without COPD, regression analysis revealed no relationship between BMI and cytokine release. In addition, AA, but not SFAs or ω-3 PUFAs reduced the basal deposition of fibronectin, type I collagen, tenascin and perlecan into the ECM in COPD fibroblasts. In non-COPD fibroblasts, AA-challenge decreased basal deposition of type I collagen and perlecan, but not fibronectin and tenascin. Conclusions This study shows that AA has disease-specific effects on inflammation and ECM protein deposition. The impaired response to AA in COPD might in part explain why obesity appears to have less detrimental effects in COPD, compared to other lung diseases.
- Published
- 2018
- Full Text
- View/download PDF
3. Heightened response to e-cigarettes in COPD
- Author
-
Jack Bozier, Sandra Rutting, Dia Xenaki, Matthew Peters, Ian Adcock, and Brian G. Oliver
- Subjects
Medicine - Published
- 2019
- Full Text
- View/download PDF
4. Dietary Fatty Acids Amplify Inflammatory Responses to Infection through p38 MAPK Signaling
- Author
-
Philip M. Hansbro, Jay C. Horvat, Lisa Wood, Jack Bozier, Razia Zakarya, Dia Xenaki, Sandra Rutting, and Brian G. Oliver
- Subjects
0301 basic medicine ,Pulmonary and Respiratory Medicine ,chemistry.chemical_classification ,medicine.medical_treatment ,Clinical Biochemistry ,Respiratory infection ,Cell Biology ,Pharmacology ,Proinflammatory cytokine ,03 medical and health sciences ,chemistry.chemical_compound ,030104 developmental biology ,0302 clinical medicine ,Cytokine ,Immune system ,030228 respiratory system ,chemistry ,medicine ,Arachidonic acid ,Lipoteichoic acid ,Interleukin 8 ,Molecular Biology ,Polyunsaturated fatty acid - Abstract
Obesity is an important risk factor for severe asthma exacerbations, which are mainly caused by respiratory infections. Dietary fatty acids, which are increased systemically in obese patients and are further increased after high-fat meals, affect the innate immune system and may contribute to dysfunctional immune responses to respiratory infection. In this study we investigated the effects of dietary fatty acids on immune responses to respiratory infection in pulmonary fibroblasts and a bronchial epithelial cell line (BEAS-2B). Cells were challenged with BSA-conjugated fatty acids (ω-6 polyunsaturated fatty acids [PUFAs], ω-3 PUFAs, or saturated fatty acids [SFAs]) +/- the viral mimic polyinosinic:polycytidylic acid (poly[I:C]) or bacterial compound lipoteichoic acid (LTA), and release of proinflammatory cytokines was measured. In both cell types, challenge with arachidonic acid (AA) (ω-6 PUFA) and poly(I:C) or LTA led to substantially greater IL-6 and CXCL8 release than either challenge alone, demonstrating synergy. In epithelial cells, palmitic acid (SFA) combined with poly(I:C) also led to greater IL-6 release. The underlying signaling pathways of AA and poly(I:C)- or LTA-induced cytokine release were examined using specific signaling inhibitors and IB. Cytokine production in pulmonary fibroblasts was prostaglandin dependent, and synergistic upregulation occurred via p38 mitogen-activated protein kinase signaling, whereas cytokine production in bronchial epithelial cell lines was mainly mediated through JNK and p38 mitogen-activated protein kinase signaling. We confirmed these findings using rhinovirus infection, demonstrating that AA enhances rhinovirus-induced cytokine release. This study suggests that during respiratory infection, increased levels of dietary ω-6 PUFAs and SFAs may lead to more severe airway inflammation and may contribute to and/or increase the severity of asthma exacerbations.
- Published
- 2019
5. Autophagy Activation in Asthma Airways Remodeling
- Author
-
Kielan Darcy McAlinden, Dia Xenaki, Saeid Ghavami, Brian G. Oliver, Deepak A. Deshpande, Pawan K. Sharma, Mehra Haghi, and Sukhwinder Singh Sohal
- Subjects
0301 basic medicine ,Pulmonary and Respiratory Medicine ,Clinical Biochemistry ,03 medical and health sciences ,0302 clinical medicine ,immune system diseases ,Medicine ,Molecular Biology ,Lung function ,Asthma ,COPD ,business.industry ,Autophagy ,Disease progression ,Cell Biology ,respiratory system ,medicine.disease ,Epithelium ,respiratory tract diseases ,030104 developmental biology ,medicine.anatomical_structure ,030228 respiratory system ,Immunology ,Immunohistochemistry ,Airway ,business - Abstract
Current asthma therapies fail to target airway remodeling that correlates with asthma severity driving disease progression that ultimately leads to loss of lung function. Macroautophagy (hereinafte...
- Published
- 2019
6. Airway smooth muscle cells from severe asthma patients with fixed airflow obstruction are responsive to steroid and bronchodilator treatment
- Author
-
Brian G. Oliver, Karosham D. Reddy, Sandra Rutting, Melissa Baraket, Gregory G. King, Katrina O. Tonga, David G. Chapman, and Dia Xenaki
- Subjects
Pulmonary and Respiratory Medicine ,medicine.drug_class ,Severe asthma ,medicine.medical_treatment ,Airflow obstruction ,Steroid ,03 medical and health sciences ,0302 clinical medicine ,Bronchodilator ,Medicine ,030212 general & internal medicine ,business.industry ,digestive, oral, and skin physiology ,Original Research Letters ,food and beverages ,Airway smooth muscle ,respiratory system ,In vitro ,respiratory tract diseases ,030228 respiratory system ,Immunology ,business ,Signalling pathways - Abstract
Asthma is characterised by recurrent symptoms associated with variable airflow obstruction and airway hyperresponsiveness, all of which are improved with combination inhaled corticosteroid (ICS)/long-acting β-agonist (LABA) treatment in mild-to-moderate asthma [1]. A proportion of patients however develop fixed airflow obstruction (FAO), despite optimised treatment. FAO is prevalent in up to 60% of patients with severe asthma and is associated with a more rapid decline in lung function and increased symptoms [2]. The underlying mechanisms of FAO in asthma are poorly understood; therefore, development of novel treatment strategies remains a challenge., Airway smooth muscle cells from severe asthma patients with FAO respond to β2-agonists and corticosteroids in vitro, and at a level similar to mild asthmatics. Intrinsic dysfunction of these signalling pathways is unlikely to contribute to FAO. https://bit.ly/3muvNsW
- Published
- 2021
7. Apoptosis signal-regulating kinase 1 inhibition attenuates human airway smooth muscle growth and migration in chronic obstructive pulmonary disease
- Author
-
Kielan Darcy McAlinden, Anudeep Kota, Deepak A. Deshpande, Brian G. Oliver, Sukhwinder Singh Sohal, Mathew Suji Eapen, Pawan K. Sharma, Dia Xenaki, and Howard Vindin
- Subjects
0301 basic medicine ,MAPK/ERK pathway ,biology ,MAP kinase kinase kinase ,business.industry ,Cell growth ,Kinase ,General Medicine ,respiratory system ,respiratory tract diseases ,03 medical and health sciences ,030104 developmental biology ,Mitogen-activated protein kinase ,Cancer research ,biology.protein ,Medicine ,ASK1 ,Protein kinase A ,business ,Platelet-derived growth factor receptor - Abstract
Increased airway smooth muscle (ASM) mass is observed in chronic obstructive pulmonary disease (COPD), which is correlated with disease severity and negatively affects lung function in these patients. Thus, there is clear unmet clinical need for finding new therapies which can target airway remodeling and disease progression in COPD. Apoptosis signal-regulating kinase 1 (ASK1) is a ubiquitously expressed mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) activated by various stress stimuli, including reactive oxygen species (ROS), tumor necrosis factor (TNF)-α, and lipopolysaccharide (LPS) and is known to regulate cell proliferation. ASM cells from COPD patients are hyperproliferative to mitogens in vitro. However, the role of ASK1 in ASM growth is not established. Here, we aim to determine the effects of ASK1 inhibition on ASM growth and pro-mitogenic signaling using ASM cells from COPD patients. We found greater expression of ASK1 in ASM bundles of COPD lung when compared with non-COPD. Pre-treatment of ASM cells with highly selective ASK1 inhibitor, TC ASK 10 resulted in a dose-dependent reduction in mitogen (FBS, PDGF, and EGF; 72 h)-induced ASM growth as measured by CyQUANT assay. Further, molecular targetting of ASK1 using siRNA in ASM cells prevented mitogen-induced cell growth. In addition, to anti-mitogenic potential, ASK1 inhibitor also prevented TGFβ1-induced migration of ASM cells in vitro. Immunoblotting revealed that anti-mitogenic effects are mediated by C-Jun N-terminal kinase (JNK) and p38MAP kinase-signaling pathways as evident by reduced phosphorylation of downstream effectors JNK1/2 and p38MAP kinases, respectively, with no effect on extracellular signal-regulated kinase (ERK) 1/2 (ERK1/2). Collectively, these findings establish the anti-mitogenic effect of ASK1 inhibition and identify a novel pathway that can be targetted to reduce or prevent excessive ASM mass in COPD.
- Published
- 2018
8. Short-chain fatty acids increase TNFα-induced inflammation in primary human lung mesenchymal cells through the activation of p38 MAPK
- Author
-
Monique A. Malouf, Brian G. Oliver, Dia Xenaki, Lisa Wood, Philip M. Hansbro, Sandra Rutting, and Jay C. Horvat
- Subjects
0301 basic medicine ,Pulmonary and Respiratory Medicine ,Adult ,Male ,medicine.medical_specialty ,Physiology ,MAP Kinase Signaling System ,Myocytes, Smooth Muscle ,Inflammation ,Receptors, Cell Surface ,p38 Mitogen-Activated Protein Kinases ,Receptors, G-Protein-Coupled ,Butyric acid ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Physiology (medical) ,Internal medicine ,medicine ,Free fatty acid receptor 3 ,Humans ,Interleukin 8 ,Lung ,Cells, Cultured ,Aged ,Chemistry ,Interleukin-6 ,Tumor Necrosis Factor-alpha ,Mesenchymal stem cell ,Interleukin-8 ,Mesenchymal Stem Cells ,Cell Biology ,Metabolism ,Fibroblasts ,Middle Aged ,Fatty Acids, Volatile ,030104 developmental biology ,Endocrinology ,030228 respiratory system ,Cell culture ,Tumor necrosis factor alpha ,Female ,medicine.symptom - Abstract
Short-chain fatty acids (SCFAs), produced as by-products of dietary fiber metabolism by gut bacteria, have anti-inflammatory properties and could potentially be used for the treatment of inflammatory diseases, including asthma. The direct effects of SCFAs on inflammatory responses in primary human lung mesenchymal cells have not been assessed. We investigated whether SCFAs can protect against tumor necrosis factor (TNF)α-induced inflammation in primary human lung fibroblasts (HLFs) and airway smooth muscle (ASM) cells in vitro. HLFs and ASM cells were exposed to SCFAs, acetate (C2:0), propionate (C3:0), and butyrate (C4:0) (0.01–25 mM) with or without TNFα, and the release of proinflammatory cytokines, IL-6, and CXCL8 was measured using ELISA. We found that none of the SCFAs suppressed TNFα-induced cytokine release. On the contrary, challenge with supraphysiological concentrations (10–25 mM), as might be used therapeutically, of propionate or butyrate in combination with TNFα resulted in substantially greater IL-6 and CXCL8 release from HLFs and ASM cells than challenge with TNFα alone, demonstrating synergistic effects. In ASM cells, challenge with acetate also enhanced TNFα-induced IL-6, but not CXCL8 release. Synergistic upregulation of IL-6 and CXCL8 was mediated through the activation of free fatty acid receptor (FFAR)3, but not FFAR2. The signaling pathways involved were further examined using specific inhibitors and immunoblotting, and responses were found to be mediated through p38 MAPK signaling. This study demonstrates that proinflammatory, rather than anti-inflammatory effects of SCFAs are evident in lung mesenchymal cells.
- Published
- 2018
9. Dietary ω-6 polyunsaturated fatty acid arachidonic acid increases inflammation, but inhibits ECM protein expression in COPD
- Author
-
Dia Xenaki, Brian G. Oliver, Sandra Rutting, Michael Papanicolaou, Philip M. Hansbro, Lisa Wood, and Alexander M. Mullin
- Subjects
Adult ,Male ,0301 basic medicine ,medicine.medical_specialty ,medicine.medical_treatment ,Respiratory System ,Gene Expression ,Tenascin ,Perlecan ,Extracellular matrix ,Pulmonary Disease, Chronic Obstructive ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Fatty Acids, Omega-6 ,Internal medicine ,ω-6 PUFAs ,medicine ,COPD ,Humans ,Cells, Cultured ,Aged ,lcsh:RC705-779 ,Inflammation ,chemistry.chemical_classification ,Extracellular Matrix Proteins ,Arachidonic Acid ,biology ,Research ,Remodelling ,lcsh:Diseases of the respiratory system ,Human pulmonary fibroblasts ,Fibroblasts ,Middle Aged ,respiratory tract diseases ,3. Good health ,Fibronectin ,030104 developmental biology ,Cytokine ,Endocrinology ,030228 respiratory system ,chemistry ,biology.protein ,Female ,Arachidonic acid ,Inflammation Mediators ,Type I collagen ,Airway inflammation ,Polyunsaturated fatty acid - Abstract
Background The obesity paradox in COPD describes protective effects of obesity on lung pathology and inflammation. However, the underlying relationships between obesity, diet and disease outcomes in COPD are not fully understood. In this study we measured the response to dietary fatty acids upon markers of inflammation and remodelling in human lung cells from people with and without COPD. Methods Pulmonary fibroblasts were challenged with ω-3 polyunsaturated fatty acids (PUFAs), ω-6 PUFAs, saturated fatty acids (SFAs) or the obesity-associated cytokine TNFα. After 48–72 h release of the pro-inflammatory cytokines interleukin (IL)-6 and CXCL8 was measured using ELISA and mRNA expression and deposition of the extracellular matrix (ECM) proteins fibronectin, type I collagen, tenascin and perlecan were measured using qPCR or ECM ELISA, respectively. Results Challenge with the ω-6 PUFA arachidonic acid (AA), but not ω-3 PUFAs or SFAs, resulted in increased IL-6 and CXCL8 release from fibroblasts, however IL-6 and CXCL8 release was reduced in COPD (n = 19) compared to non-COPD (n = 36). AA-induced cytokine release was partially mediated by downstream mediators of cyclooxygenase (COX)-2 in both COPD and non-COPD. In comparison, TNFα-induced IL-6 and CXCL8 release was similar in COPD and non-COPD, indicating a specific interaction of AA in COPD. In patients with or without COPD, regression analysis revealed no relationship between BMI and cytokine release. In addition, AA, but not SFAs or ω-3 PUFAs reduced the basal deposition of fibronectin, type I collagen, tenascin and perlecan into the ECM in COPD fibroblasts. In non-COPD fibroblasts, AA-challenge decreased basal deposition of type I collagen and perlecan, but not fibronectin and tenascin. Conclusions This study shows that AA has disease-specific effects on inflammation and ECM protein deposition. The impaired response to AA in COPD might in part explain why obesity appears to have less detrimental effects in COPD, compared to other lung diseases. Electronic supplementary material The online version of this article (10.1186/s12931-018-0919-4) contains supplementary material, which is available to authorized users.
- Published
- 2018
10. Lung cells from people with COPD are hyperresponsive to E-cigarette vapour
- Author
-
Jack Bozier, Ian M. Adcock, Brian G. Oliver, and Dia Xenaki
- Subjects
COPD ,Lung ,business.industry ,medicine.medical_treatment ,Pharmacology ,medicine.disease ,Nicotine replacement therapy ,respiratory tract diseases ,Nicotine ,chemistry.chemical_compound ,medicine.anatomical_structure ,chemistry ,medicine ,Smoking cessation ,MTT assay ,Interleukin 8 ,business ,Menthol ,medicine.drug - Abstract
E-cigarettes are proposed as an alternative to smoking and as nicotine replacement therapy. There is confusion around their safety stemming from contradictory findings across multiple studies. Patients with COPD find it difficult to quit smoking and as such e-cigarettes are an attractive option. The aim of this study was to determine the inflammatory response to e-cigarettes in cells from people with and without COPD under realistic physiological conditions. Primary human airway smooth muscle cells were isolated from explanted and resected lung tissue from COPD patients and smokers without COPD. Cells were stimulated with increasing concentrations of 18mg/ml nicotine and 0mg/ml nicotine (tobacco and menthol flavoured, Vaper Empire) E-vapour extract for 24 hours. An MTT assay was performed to determine cytotoxicity and ELISA was used to assess IL-6 and CXCL8 production. Tobacco and Menthol (18mg/ml nicotine, 0mg/ml nicotine) E-vapour extracts were cytotoxic to cells (n=9-14, p≤0.0001), cytotoxicity of E-vapour was increased in aerosols created at higher temperatures. All 4 E-vapour extracts stimulated CXCL8 production compared to unstimulated controls (n=14, p E-cigarettes have the potential to contribute to the pathology of COPD. Cytotoxicity can cause cell death and ineffective repair, as seen in both the airways and parenchyma in COPD. Our data suggests that COPD patients should not use them as a smoking cessation aid or cigarette replacement.
- Published
- 2018
11. Dietary omega-6, but not omega-3, polyunsaturated or saturated fatty acids increase inflammation in primary lung mesenchymal cells
- Author
-
Lisa Wood, Sandra Rutting, Brian G. Oliver, Philip M. Hansbro, Dia Xenaki, Jay C. Horvat, and Edmund M.T. Lau
- Subjects
0301 basic medicine ,Pulmonary and Respiratory Medicine ,Male ,medicine.medical_specialty ,Physiology ,MAP Kinase Signaling System ,medicine.medical_treatment ,Inflammation ,Proinflammatory cytokine ,03 medical and health sciences ,chemistry.chemical_compound ,Phosphatidylinositol 3-Kinases ,0302 clinical medicine ,Physiology (medical) ,Internal medicine ,Fatty Acids, Omega-6 ,Fatty Acids, Omega-3 ,medicine ,Humans ,Interleukin 8 ,Interleukin 6 ,Extracellular Signal-Regulated MAP Kinases ,Lung ,Aged ,chemistry.chemical_classification ,Innate immune system ,biology ,Interleukin-6 ,Interleukin-8 ,NF-kappa B ,Mesenchymal Stem Cells ,Cell Biology ,Middle Aged ,030104 developmental biology ,Endocrinology ,Cytokine ,030228 respiratory system ,chemistry ,biology.protein ,Arachidonic acid ,Female ,medicine.symptom ,Polyunsaturated fatty acid - Abstract
Obesity is an important risk factor for developing severe asthma. Dietary fatty acids, which are increased in sera of obese individuals and after high-fat meals, activate the innate immune system and induce inflammation. This study investigated whether dietary fatty acids directly cause inflammation and/or synergize with obesity-induced cytokines in primary human pulmonary fibroblasts in vitro. Fibroblasts were challenged with BSA-conjugated fatty acids [ω-6 polyunsaturated fatty acids (PUFAs) and ω-3 PUFAs or saturated fatty acids (SFAs)], with or without TNF-α, and release of the proinflammatory cytokines, IL-6 and CXCL8, was measured. We found that the ω-6 PUFA arachidonic acid (AA), but not ω-3 PUFAs or SFAs, upregulates IL-6 and CXCL8 release. Combined AA and TNF-α challenge resulted in substantially greater cytokine release than either alone, demonstrating synergy. Synergistic upregulation of IL-6, but not CXCL8, was mainly mediated via cyclooxygenase (COX). Inhibition of p38 MAPK reduced CXCL8 release, induced by AA and TNF-α alone, but not in combination. Synergistic CXCL8 release, following AA and TNF-α challenge, was not medicated via a single signaling pathway (MEK1, JNK, phosphoinositide 3-kinase, and NF-κB) nor by hyperactivation of NF-κB or p38. To investigate if these findings occur in other airway cells, effects of AA in primary human airway smooth muscle (ASM) cells and human bronchial epithelial cells were also investigated. We found proinflammatory effects in ASM cells but not epithelial cells. This study suggests that diets rich in ω-6 PUFAs might promote airway inflammation via multiple pathways, including COX-dependent and -independent pathways, and in an obese person, may lead to more severe airway inflammation.
- Published
- 2018
12. Targeting ASK1 in preventing airway smooth muscle growth: Implications for airway remodeling in COPD
- Author
-
Pawan K. Sharma, Deepak A. Deshpande, Brian G. Oliver, and Dia Xenaki
- Subjects
biology ,MAP kinase kinase kinase ,Cell growth ,business.industry ,Kinase ,Inflammation ,respiratory system ,Airway obstruction ,medicine.disease ,respiratory tract diseases ,Immunology ,biology.protein ,Cancer research ,Medicine ,Gene silencing ,ASK1 ,medicine.symptom ,business ,Platelet-derived growth factor receptor - Abstract
Airway remodeling is a hallmark feature of individuals with COPD. Increased airway smooth muscle (ASM) mass, and ASM thickness is correlated with severity of the disease and has been described to negatively impact lung function in COPD. Current medications control inflammation and reverse airway obstruction effectively yet have limited effect on remodeling. Apoptosis signal-regulating kinase 1 (ASK1) is a ubiquitously expressed MAPK kinase kinase (MAP3K), activated by various stress stimuli, including ROS, TNF-α, and LPS. ASK1 affects multiple cellular functions, including survival, differentiation, and the innate immune response and has been reported to be involved in the pathogenesis of various human diseases. However, no reported study has demonstrated a role for ASK1 in airway remodeling. In this study we aimed to determine the effects of ASK1 inhibition on ASM growth and pro-mitogenic signaling. We found expression of ASK1 on human lung tissue and primary human ASM cells. Pre-treatment of human ASM cells with potent and orally available ASK1 inhibitor, TCASK10 resulted in a dose-dependent reduction in mitogen (FBS, PDGF and EGF)-induced ASM growth as measured by CyQuant assay. Furthermore, the effectiveness of this pharmacological inhibition was established and replicated in gene silencing experiments where ASK1 siRNA inhibited mitogen-induced human ASM cell growth. Immunoblotting revealed that the anti-mitogenic effect of ASK1 inhibition or silencing is mediated by JNK-signaling pathway. Collectively, these findings establish the anti-mitogenic effect of ASK1 inhibition and identify a novel pathway that can be targeted to reduce or prevent excessive ASM mass in COPD.
- Published
- 2016
13. Interaction of dietary fatty acids with obesity induced cytokines in primary human pulmonary fibroblasts
- Author
-
Dia Xenaki, Sandra Rutting, Phil Hansbro, Brian G. Oliver, Lisa Wood, and Qi Ge
- Subjects
chemistry.chemical_classification ,medicine.medical_specialty ,Innate immune system ,biology ,business.industry ,Inflammation ,chemistry.chemical_compound ,Endocrinology ,chemistry ,Docosahexaenoic acid ,Internal medicine ,Immunology ,medicine ,biology.protein ,Arachidonic acid ,Tumor necrosis factor alpha ,Interleukin 8 ,adipocyte protein 2 ,medicine.symptom ,business ,Polyunsaturated fatty acid - Abstract
Introduction: Obesity is an important risk factor for developing severe asthma. Dietary fatty acids, increased in the serum of obese people, activate systemic innate immune responses. Furthermore, we have shown that a single high fat meal increases airway inflammation and impairs bronchodilator recovery in asthma. Aims: To investigate whether dietary fatty acids directly cause inflammation and/or synergise with obesity induced cytokines. Methods: Primary human pulmonary fibroblasts were incubated with BSA-conjugated fatty acids for 24hr, before stimulation with TNFα for another 24hr. IL6 and CXCL8 release was measured using ELISA. IL6 acts as a general marker for inflammation and CXCL8 is a potent neutrophilic chemoattractant. The following ω-6 and 3 polyunsaturated fatty acids were used: arachidonic acid (AA) and docosahexaenoic acid (DHA) (1, 10, 100µM). Results: AA induced substantial IL6 (n=11, P Conclusion: These findings suggest that dietary fatty acids are important modulators of inflammatory responses and that there is an interaction between fatty acids and TNFα, resulting in a synergetic inflammatory response in pulmonary fibroblasts. This could indicate that obese asthmatics compared to lean individuals, are more prone to airway inflammation after a high fat meal.
- Published
- 2016
14. F3/contactin and TAG1 play antagonistic roles in the regulation of sonic hedgehog-induced cerebellar granule neuron progenitor proliferation
- Author
-
Andrew J.W. Furley, Takeshi Sakurai, Dia Xenaki, Martin Grumet, Kyoji Ohyama, Gianfranco Gennarini, Indira B. Martin, and Lynn Yoshida
- Subjects
Contactin 1 ,animal structures ,Cellular differentiation ,Morphogenesis ,Biology ,Mice ,Paracrine signalling ,Cerebellum ,Contactin 2 ,Animals ,Hedgehog Proteins ,Progenitor cell ,Sonic hedgehog ,Molecular Biology ,Cells, Cultured ,Cell Proliferation ,Neurons ,Cell adhesion molecule ,Cell Differentiation ,Anatomy ,Mice, Mutant Strains ,Cell biology ,embryonic structures ,biology.protein ,Signal transduction ,Signal Transduction ,Research Article ,Developmental Biology - Abstract
Modulation of the sonic hedgehog (SHH) pathway is a crucial factor in cerebellar morphogenesis. Stimulation of granule neuron progenitor (GNP) proliferation is a central function of SHH signalling, but how this is controlled locally is not understood. We show that two sequentially expressed members of the contactin (CNTN) family of adhesion molecules, TAG1 and F3, act antagonistically to control SHH-induced proliferation: F3 suppresses SHH-induced GNP proliferation and induces differentiation, whereas TAG1 antagonises F3. Production of GNPs in TAG1-null mice is delayed and reduced. F3 and TAG1 colocalise on GNPs with the related L1-like adhesion molecule NrCAM, and F3 fails to suppress the SHH-induced proliferation of NrCAM-deficient GNPs. We show that F3 and SHH both primarily affect a group of intermediate GNPs (IPs), which, though actively dividing, also express molecules associated with differentiation, including β-tubulin III (TuJ1) and TAG1. In vivo, intermediate progenitors form a discrete layer in the middle of the external germinal layer (mEGL), while F3 becomes expressed on the axons of postmitotic granule neurons as they leave the inner EGL (iEGL). We propose, therefore, that F3 acts as a localised signal in the iEGL that induces SHH-stimulated cells in the overlying mEGL to exit cell cycle and differentiate. By contrast, expression of TAG1 on GNPs antagonises this signal in the mEGL, preventing premature differentiation and sustaining GNP expansion in a paracrine fashion. Together, these findings indicate that CNTN and L1-like proteins play a significant role in modulating SHH-induced neuronal precursor proliferation.
- Published
- 2011
15. Short-chain fatty acids increase TNFα-induced inflammation in primary human lung mesenchymal cells through the activation of p38 MAPK.
- Author
-
Rutting, Sandra, Dia Xenaki, Malouf, Monique, Horvat, Jay C., Wood, Lisa G., Hansbro, Philip M., and Oliver, Brian G.
- Subjects
- *
MITOGEN-activated protein kinases , *TUMOR necrosis factors , *MESENCHYMAL stem cells - Abstract
Short-chain fatty acids (SCFAs), produced as by-products of dietary fiber metabolism by gut bacteria, have antiinflammatory properties and could potentially be used for the treatment of inflammatory diseases, including asthma. The direct effects of SCFAs on inflammatory responses in primary human lung mesenchymal cells have not been assessed. We investigated whether SCFAs can protect against tumor necrosis factor (TNF)α-induced inflammation in primary human lung fibroblasts (HLFs) and airway smooth muscle (ASM) cells in vitro. HLFs and ASM cells were exposed to SCFAs, acetate (C2:0), propionate (C3:0), and butyrate (C4:0) (0.01-25 mM) with or without TNFα, and the release of proinflammatory cytokines, IL-6, and CXCL8 was measured using ELISA. We found that none of the SCFAs suppressed TNFα-induced cytokine release. On the contrary, challenge with supraphysiological concentrations (10-25 mM), as might be used therapeutically, of propionate or butyrate in combination with TNFα resulted in substantially greater IL-6 and CXCL8 release from HLFs and ASM cells than challenge with TNFα alone, demonstrating synergistic effects. In ASM cells, challenge with acetate also enhanced TNFα-induced IL-6, but not CXCL8 release. Synergistic upregulation of IL-6 and CXCL8 was mediated through the activation of free fatty acid receptor (FFAR)3, but not FFAR2. The signaling pathways involved were further examined using specific inhibitors and immunoblotting, and responses were found to be mediated through p38 MAPK signaling. This study demonstrates that proinflammatory, rather than anti-inflammatory effects of SCFAs are evident in lung mesenchymal cells. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
16. MDM2 Mediated Nuclear Exclusion of p53 Attenuates Etoposide-Induced Apoptosis in Neuroblastoma Cells
- Author
-
Christine M. Chresta, John A. Hickman, Ana M. Rodriguez-Lopez, Tim O. B. Eden, and Dia Xenaki
- Subjects
Transcriptional Activation ,Apoptosis ,Neuroblastoma ,Proto-Oncogene Proteins ,Tumor Cells, Cultured ,medicine ,Humans ,Cytotoxic T cell ,Gene Silencing ,Nuclear protein ,Nuclear export signal ,Etoposide ,Cell Nucleus ,Pharmacology ,biology ,Nuclear Proteins ,Proto-Oncogene Proteins c-mdm2 ,Antineoplastic Agents, Phytogenic ,Cytoplasm ,Cell culture ,Cancer research ,biology.protein ,Molecular Medicine ,Mdm2 ,Tumor Suppressor Protein p53 ,DNA Damage ,Subcellular Fractions ,medicine.drug - Abstract
The p53 gene in neuroblastoma tumors (NB) is rarely mutated but the protein accumulates in the cytoplasm. Because p53 can mediate the cytotoxic effects of chemotherapeutic agents, it is important to determine whether accumulation of p53 in the cytoplasm impairs p53 function. Data presented here indicate that hyperactive nuclear export of p53 suppresses etoposide-induced apoptosis but does not prevent growth arrest. We compared p53 function in a pair of NB subclones. Our data show etoposide induces complete trans-location of p53 to the nucleus and activation of apoptosis in the neuroblastic NB cell line SH-SY5Y (N-type), which expresses low levels of MDM2. However, in Schwann cell-like SH-EP1 cells (S-type), which have up to 10-fold higher levels of MDM2, p53 accumulates in the cytoplasm and the cells are extremely resistant to etoposide-induced apoptosis. Notably, when MDM2 expression is inhibited in S-type cells, with a phosphorothioated antisense oligonucleotide (AS5), then p53 accumulates in the nucleus and the SH-EP1 cells undergo apoptosis. Surprisingly, induction of p21 and G1-arrest are not attenuated in S-type cells, despite the predominantly cytoplasmic location of p53. Whereas, G1-arrest is attenuated in the SH-SY5Y cells, which have high levels of nuclear p53. Taken together, these findings suggest attenuation of G1-arrest is related to the differentiation status of neuroblastomas and occurs downstream of p53 nuclear accumulation. These results demonstrate for the first time that hyperactive nuclear export of p53 attenuates chemotherapy-induced apoptosis in NB cells, and our findings suggest that inhibitors of MDM2 may enhance the therapeutic efficacy of etoposide by promoting apoptosis rather than trans-differentiation.
- Published
- 2001
17. F3/Contactin acts as a modulator of neurogenesis during cerebral cortex development
- Author
-
Dia Xenaki, Angela Polizzi, Antonella Bizzoca, Andrew J.W. Furley, Marco F. Pinto, Patrizia Corsi, and Gianfranco Gennarini
- Subjects
Axonal glycoproteins ,Neurogenesis ,Notch signaling pathway ,Biology ,Animals, Genetically Modified ,Mice ,Downregulation and upregulation ,Contactin 1 ,medicine ,Animals ,Humans ,Molecular Biology ,Notch signaling ,Regulation of gene expression ,Cerebral Cortex ,Neurons ,Receptors, Notch ,Cortical precursor proliferation/differentiation ,Wild type ,Gene Expression Regulation, Developmental ,Cell Differentiation ,Cell Biology ,Anatomy ,Transgenic misexpression ,Cell biology ,Cortex (botany) ,Gene regulation ,Corticogenesis ,medicine.anatomical_structure ,Cerebral cortex ,Developmental Biology ,Signal Transduction - Abstract
The expression of the cell recognition molecule F3/Contactin (CNTN1) is generally associated with the functions of post-mitotic neurons. In the embryonic cortex, however, we find it expressed by proliferating ventricular zone (VZ) precursors. In contrast to previous findings in the developing cerebellum, F3/Contactin transgenic overexpression in the early cortical VZ promotes proliferation and expands the precursor pool at the expense of neurogenesis. At later stages, when F3/Contactin levels subside, however, neurogenesis resumes, suggesting that F3/Contactin expression in the VZ is inversely related to neurogenesis and plays a role in a feedback control mechanism, regulating the orderly progression of cortical development. The modified F3/Contactin profile therefore results in delayed corticogenesis, as judged by downregulation in upper and lower layer marker expression and by BrdU birth dating, indicating that, in this transgenic model, increased F3/Contactin levels counteract neuronal precursor commitment. These effects also occur in primary cultures and are reproduced by addition of an F3/Fc fusion protein to wild type cultures. Together, these data indicate a completely novel function for F3/Contactin. Parallel changes in the generation of the Notch Intracellular Domain and in the expression of the Hes-1 transcription factor indicate that activation of the Notch pathway plays a role in this phenotype, consistent with previous in vitro reports that F3/Contactin is a Notch1 ligand.
- Published
- 2011
18. Bcr-Abl-mediated molecular mechanism for apoptotic suppression in multipotent haemopoietic cells: a role for PKCbetaII
- Author
-
Andrew Pierce, Anthony D. Whetton, Dia Xenaki, P. Jane Owen-Lynch, and Nick Underhill-Day
- Subjects
animal structures ,Cell Survival ,Fusion Proteins, bcr-abl ,Apoptosis ,Biology ,hemic and lymphatic diseases ,Proto-Oncogene Proteins ,Protein Kinase C beta ,STAT5 Transcription Factor ,Humans ,Progenitor cell ,Phosphorylation ,Protein kinase C ,Protein Kinase C ,Interleukin 3 ,Mitogen-Activated Protein Kinase 1 ,ABL ,Mitogen-Activated Protein Kinase 3 ,Multipotent Stem Cells ,Cell Biology ,Janus Kinase 2 ,Protein-Tyrosine Kinases ,Hematopoietic Stem Cells ,Milk Proteins ,Coculture Techniques ,Cell biology ,DNA-Binding Proteins ,Haematopoiesis ,Multipotent Stem Cell ,Mutation ,Cancer research ,Trans-Activators ,Interleukin-3 ,Signal transduction ,Mitogen-Activated Protein Kinases ,Tyrosine kinase ,Signal Transduction - Abstract
Bcr-Abl protein tyrosine kinase (PTK) activity is a feature of chronic myeloid leukaemia and confers a survival advantage on haemopoietic progenitor cells. We have expressed conditional mutant of the Bcr-Abl PTK in the FDCP-Mix A4 multipotent haematopoietic cell line in order to examine the molecular mechanisms whereby Bcr-Abl PTK leads to enhanced cell survival under conditions in which normal cells die. Activation of Bcr-Abl PTK does not phosphorylate or activate either ERK-1/2 or JAK-2/STAT-5b, suggesting that these signal transduction pathways are not involved in Abl PTK-mediated suppression of apoptosis in FDCP-Mix cells. However, protein kinase C (PKC) does have a role to play. Inhibition of PKC results in a reversal of Bcr-Abl PTK-mediated survival in the absence of growth factor and Bcr-Abl stimulates translocation of the PKCbetaII isoform to the nucleus. Furthermore, expression of a constitutively activated PKCbetaII in haemopoietic progenitor FDCP-Mix cells stimulates enhanced cell survival when IL-3 is withdrawn. However, expression of this constitutively activated PKC isoform does not suppress cytotoxic drug-induced apoptosis. Thus Bcr-Abl PTK has pleiotropic effects which can suppress cell death induced by a number of stimuli.
- Published
- 2003
19. Additional file 1: of Dietary Ď -6 polyunsaturated fatty acid arachidonic acid increases inflammation, but inhibits ECM protein expression in COPD
- Author
-
Rutting, Sandra, Papanicolaou, Michael, Dia Xenaki, Wood, Lisa, Mullin, Alexander, Hansbro, Philip, and Oliver, Brian
- Subjects
respiratory system ,respiratory tract diseases ,3. Good health - Abstract
Figure S1. Similar response to arachidonic acid in patients with non-smoking related end-stage lung disease and patients who underwent lung resection for thoracic malignancies. (DOC 153 kb)
20. Additional file 1: of Dietary Ď -6 polyunsaturated fatty acid arachidonic acid increases inflammation, but inhibits ECM protein expression in COPD
- Author
-
Rutting, Sandra, Papanicolaou, Michael, Dia Xenaki, Wood, Lisa, Mullin, Alexander, Hansbro, Philip, and Oliver, Brian
- Subjects
respiratory system ,respiratory tract diseases ,3. Good health - Abstract
Figure S1. Similar response to arachidonic acid in patients with non-smoking related end-stage lung disease and patients who underwent lung resection for thoracic malignancies. (DOC 153 kb)
21. NrCAM modulates sonic hedgehog signalling by controlling smoothened translocation in the cilium
- Author
-
O Weeranantanapan, Andrew J.W. Furley, Dia Xenaki, and B Basu
- Subjects
Genetics ,biology ,Cilium ,Mutant ,Wild type ,Cell Biology ,Molecular medicine ,Cell biology ,embryonic structures ,Poster Presentation ,biology.protein ,Sonic hedgehog ,Receptor ,Smoothened ,Developmental biology - Abstract
Objective: Cerebellar development involves a spurt of proliferation in external granule layer (EGL) in response to shh, causing granule neuron precursors (GNPs) to proliferate. These cells subsequently differentiate into granule neurons in the inner granule layer (IGL). F3, a CNTN family molecule, can interact with NrCAM to switch GNPs from proliferation to differentiation. We aim to identify the role of NrCAM in the sonic hedgehog response in GNPs. Methods: GNPs were extracted from wildtype and NrCAM mutant P5 cerebella using Percoll gradient centrifugation. Proliferation response to shh was measured using EdU in presence/absence of F3-Fc. GNPs treated with shh/SAG were stained with antibodies against Arl13b and smo to look for differences in cilia size and smo occupancy after different treatment times. Results: NrCAM-/- and wildtype GNPs both proliferated equally in response to shh. F3 was found to block the proliferation response in wildtype but not in NrCAM-/- GNPs. F3 also failed to affect proliferation in SmoA1 GNPs with a constitutively active smo suggesting that the F3-NrCAM mediated block lay upstream of Smo. NrCAM was detected in wildtype cilia and Smo localization was affected in NrCAM-/- GNPs. No differences in cilia length were observed. Conclusion: Our results suggest that NrCAM affects shh-mediated proliferation by controlling smo movement into the cilium.
- Full Text
- View/download PDF
22. F3/contactin and TAG1 play antagonistic roles in the regulation of sonic hedgehog-induced cerebellar granule neuron progenitor proliferation.
- Author
-
Dia Xenaki, Martin, Indira B., Yoshida, Lynn, Ohyama, Kyoji, Gennarini, Gianfranco, Grumet, Martin, Sakurai, Takeshi, and Furley, Andrew J. W.
- Subjects
- *
NEURONS - Abstract
An abstract of the article "F3/Contactin and TAG1 Play Antagonistic Roles in the Regulation of Sonic Hedgehog-Induced Cerebellar Granule Neuron Progenitor Proliferation," by Dia Xenaki and colleagues is presented.
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.